• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Cipla partners with MannKind for Afrezza – inhaled insulin expressbpd
    May 11, 2018
    Cipla has entered into an exclusive marketing and distribution agreement with US-based MannKind Corporation for Afrezza in India. It is the only USFDA approved inhaled insulin available for patients suffering from diabetes.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service